Demographic variable | Intervention (n = 17) | Usual care (n = 16) | p | |
Gender (male) | 13 (76%) | 12 (75%) | 1.0000 | |
Age (years ± SD) | 61.94 ± 12.19 | 64.12 ± 9.27 | 0.9857 | |
Living situation (living alone) | 2 (11%) | 2 (12%) | 0.6880 | |
Employment (employed) | 5 (29%) | 3 (19%) | 1.0000 | |
Body weight (kilograms) | 66.6 ± 16.98 | 61.67 ± 10.35 | 0.7098 | |
Cardiac characteristics | ||||
Etiology of heart failure | ||||
Dilated cardiomyopathy | 6 (36%) | 5 (32%) | 1.0000 | |
Ischemic heart disease | 5 (29%) | 7 (44%) | 0.4813 | |
Valvular disease | 1 (6%) | 0 | 1.0000 | |
Hypertrophic cardiomyopathy | 0 | 2 (12%) | 0.2273 | |
Others | 5 (29%) | 2 (12%) | 0.3983 | |
NYHA functional class | ||||
I | 5 (29%) | 5 (31%) | 1.0000 | |
II | 10 (59%) | 9 (56%) | 1.0000 | |
III | 2 (11%) | 2 (13%) | 1.0000 | |
LVEF | 42.97 ± 11.48 | 41.91 ± 9.61 | 0.8996 | |
BNP | 204.90 ± 196.45 | 344.59 ± 384.86 | 0.3440 | |
Treatment | ||||
Medication | ||||
Beta blocker | 16 (94%) | 14 (88%) | 1.0000 | |
ACE/ARB | 8 (48%) | 6 (38%) | 0.7283 | |
Diuretics | 11 (65%) | 10 (63%) | 1.0000 | |
Device | ||||
ICD | 11 (64%) | 10 (62%) | 1.0000 | |
CRT-D | 6 (36%) | 6 (38%) | 1.0000 |